166 related articles for article (PubMed ID: 35142956)
21. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
Li J; Ke J; Fang J; Chen JP
J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239
[TBL] [Abstract][Full Text] [Related]
22. MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival.
He D; Miao H; Xu Y; Xiong L; Wang Y; Xiang H; Zhang H; Zhang Z
PLoS One; 2014; 9(11):e112930. PubMed ID: 25411783
[TBL] [Abstract][Full Text] [Related]
23. The long non-coding RNA DKFZp434J0226 regulates the alternative splicing process through phosphorylation of SF3B6 in PDAC.
Li J; Tong H; Li D; Jiang Q; Zhang Y; Tang W; Jin D; Chen S; Qin X; Zhang S; Xue R
Mol Med; 2021 Aug; 27(1):95. PubMed ID: 34470609
[TBL] [Abstract][Full Text] [Related]
24. NF45 overexpression is associated with poor prognosis and enhanced cell proliferation of pancreatic ductal adenocarcinoma.
Wan C; Gong C; Ji L; Liu X; Wang Y; Wang L; Shao M; Yang L; Fan S; Xiao Y; Wang X; Li M; Zhou G; Zhang Y
Mol Cell Biochem; 2015 Dec; 410(1-2):25-35. PubMed ID: 26276310
[TBL] [Abstract][Full Text] [Related]
25. Src-mediated phosphorylation converts FHL1 from tumor suppressor to tumor promoter.
Wang X; Wei X; Yuan Y; Sun Q; Zhan J; Zhang J; Tang Y; Li F; Ding L; Ye Q; Zhang H
J Cell Biol; 2018 Apr; 217(4):1335-1351. PubMed ID: 29434030
[TBL] [Abstract][Full Text] [Related]
26. FHL1 and Smad4 synergistically inhibit vascular endothelial growth factor expression.
Zhou Z; Lu J; Dou J; Lv Z; Qin X; Lin J
Mol Med Rep; 2013 Feb; 7(2):649-53. PubMed ID: 23184087
[TBL] [Abstract][Full Text] [Related]
27. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis.
Guo X; Zhou Q; Su D; Luo Y; Fu Z; Huang L; Li Z; Jiang D; Kong Y; Li Z; Chen R; Chen C
Mol Cancer; 2020 May; 19(1):83. PubMed ID: 32375768
[TBL] [Abstract][Full Text] [Related]
28. Aberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progression.
Hasselluhn MC; Schmidt GE; Ellenrieder V; Johnsen SA; Hessmann E
Cell Death Dis; 2019 Jun; 10(6):446. PubMed ID: 31171768
[TBL] [Abstract][Full Text] [Related]
29. SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer.
Liu M; Qin Y; Hu Q; Liu W; Ji S; Xu W; Fan G; Ye Z; Zhang Z; Xu X; Yu X; Zhuo Q
Cancer Lett; 2021 Feb; 499():265-278. PubMed ID: 33232789
[TBL] [Abstract][Full Text] [Related]
30. FHL3 promotes pancreatic cancer invasion and metastasis through preventing the ubiquitination degradation of EMT associated transcription factors.
Li P; Cao G; Zhang Y; Shi J; Cai K; Zhen L; He X; Zhou Y; Li Y; Zhu Y; Xiong M; Wu Y
Aging (Albany NY); 2020 Jan; 12(1):53-69. PubMed ID: 31935687
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of FHL1 inhibits cigarette smoke extract-induced proliferation in pulmonary arterial smooth muscle cells.
Li Y; Pu G; Chen C; Yang L
Mol Med Rep; 2015 Sep; 12(3):3801-3808. PubMed ID: 25975448
[TBL] [Abstract][Full Text] [Related]
32. Neoplastic transformation and tumorigenesis associated with overexpression of IMUP-1 and IMUP-2 genes in cultured NIH/3T3 mouse fibroblasts.
Ryoo ZY; Jung BK; Lee SR; Kim MO; Kim SH; Kim HJ; Ahn JY; Lee TH; Cho YH; Park JH; Kim JK
Biochem Biophys Res Commun; 2006 Oct; 349(3):995-1002. PubMed ID: 16962562
[TBL] [Abstract][Full Text] [Related]
33. FHL1 promotes glioblastoma aggressiveness through regulating EGFR expression.
Sun L; Chen L; Zhu H; Li Y; Chen CC; Li M
FEBS Lett; 2021 Jan; 595(1):85-98. PubMed ID: 33053208
[TBL] [Abstract][Full Text] [Related]
34. LncRNA PWAR6 regulates proliferation and migration by epigenetically silencing YAP1 in tumorigenesis of pancreatic ductal adenocarcinoma.
Huang S; Li Y; Hu J; Li L; Liu Z; Guo H; Jiang B; Chen J; Li J; Xiang X; Deng J; Xiong J
J Cell Mol Med; 2021 May; 25(9):4275-4286. PubMed ID: 33834618
[TBL] [Abstract][Full Text] [Related]
35. Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma.
Fu D; Yan J; Zhang Z; Liu Y; Ma X; Ding J; Yang S; Zhao R; Chang A; Gao C; Liu J; Zhao T; Wang X; Huang C; Gao S; Ma Y; Tang B; Feng Y; Wang H; Hao J
Cancer Biol Med; 2023 Jun; 20(8):599-626. PubMed ID: 37381714
[TBL] [Abstract][Full Text] [Related]
36. FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth.
Ding L; Niu C; Zheng Y; Xiong Z; Liu Y; Lin J; Sun H; Huang K; Yang W; Li X; Ye Q
J Cell Mol Med; 2011 Jan; 15(1):72-85. PubMed ID: 19840196
[TBL] [Abstract][Full Text] [Related]
37. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W
Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395
[TBL] [Abstract][Full Text] [Related]
38. MiR-410 is overexpressed in liver and colorectal tumors and enhances tumor cell growth by silencing FHL1 via a direct/indirect mechanism.
Wang Y; Fu J; Jiang M; Zhang X; Cheng L; Xu X; Fan Z; Zhang J; Ye Q; Song H
PLoS One; 2014; 9(10):e108708. PubMed ID: 25272045
[TBL] [Abstract][Full Text] [Related]
39. FHL family members suppress vascular endothelial growth factor expression through blockade of dimerization of HIF1α and HIF1β.
Lin J; Qin X; Zhu Z; Mu J; Zhu L; Wu K; Jiao H; Xu X; Ye Q
IUBMB Life; 2012 Nov; 64(11):921-30. PubMed ID: 23086815
[TBL] [Abstract][Full Text] [Related]
40. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion.
He D; Huang C; Zhou Q; Liu D; Xiong L; Xiang H; Ma G; Zhang Z
Oncotarget; 2017 Mar; 8(12):20165-20178. PubMed ID: 28423622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
